Demystifying Immunotherapy in Prostate Cancer: Understanding Current and Future Treatment Strategies

Yazar: Madan, Ravi A., Gulley, James L., Kantoff, Philip W.
Baskı/Yayın Bilgisi 2013

Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer

Yazar: Kantoff, Philip W., Gulley, James L., Pico-Navarro, Cesar
Yayımlandı J Clin Oncol (2016)

A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research

Yazar: Laccetti, Andrew L, Morris, Michael J, Kantoff, Philip W
Yayımlandı Onco Targets Ther (2020)

Cancer nanomedicine: progress, challenges and opportunities

Yazar: Shi, Jinjun, Kantoff, Philip W., Wooster, Richard, Farokhzad, Omid C.
Yayımlandı Nat Rev Cancer (2016)

Contemporary Trends in Low-Risk Prostate Cancer: Risk Assessment and Treatment

Yazar: Cooperberg, Matthew R., Broering, Jeannette M., Kantoff, Philip W., Carroll, Peter R.
Baskı/Yayın Bilgisi 2007

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer

Yazar: Gui, Bin, Hsieh, Chen-Lin, Kantoff, Philip W., Kibel, Adam S., Jia, Li
Yayımlandı PLoS One (2017)

TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?

Yazar: Stopsack, Konrad H., Mucci, Lorelei A., Antonarakis, Emmanuel S., Nelson, Peter S., Kantoff, Philip W.
Yayımlandı Cancer Discov (2020)

Prostate Cancer Immunotherapy

Yazar: May, Kenneth F., Gulley, James L., Drake, Charles G., Dranoff, Glenn, Kantoff, Philip W.
Baskı/Yayın Bilgisi 2011

Emerging players in prostate cancer: long non-coding RNAs

Yazar: Sun, Tong, Ye, Huihui, Wu, Chin-Lee, Lee, Gwo-Shu Mary, Kantoff, Philip W
Yayımlandı Am J Clin Exp Urol (2014)

Current treatment strategies for advanced prostate cancer

Yazar: Komura, Kazumasa, Sweeney, Christopher J., Inamoto, Teruo, Ibuki, Naokazu, Azuma, Haruhito, Kantoff, Philip W.
Yayımlandı Int J Urol (2017)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

Yazar: Braunstein, Lior Z., Chen, Ming-Hui, Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.
Baskı/Yayın Bilgisi 2014

Physical and Emotional Health Information Needs and Preferences of Long-Term Prostate Cancer Survivors

Yazar: Zhou, Eric S., Bober, Sharon L., Nekhlyudov, Larissa, Hu, Jim C., Kantoff, Philip W., Recklitis, Christopher J.
Yayımlandı Patient Educ Couns (2016)

Predictors of duration of abiraterone acetate in men with castration resistant prostate cancer

Yazar: McKay, Rana R., Werner, Lillian, Fiorillo, Matthew, Nakabayashi, Mari, Kantoff, Philip W., Taplin, Mary-Ellen
Yayımlandı Prostate Cancer Prostatic Dis (2016)

A genetic variation of SOD2 does not determine duration of response to androgen deprivation therapy for prostate cancer

Yazar: Xie, Wanling, Drouin, Sarah, Nakabayashi, Mari, Pomerantz, Mark, Lee, Gwo-Shu Mary, Kantoff, Philip W., Sharifi, Nima
Yayımlandı Prostate (2016)

Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death

Yazar: Sanford, Nina N., Chen, Ming-Hui, Loffredo, Marian, Renshaw, Andrew, Kantoff, Philip W., D’Amico, Anthony V.
Yayımlandı Prostate Cancer Prostatic Dis (2016)

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

Yazar: Giovannucci, Edward, Stampfer, Meir J., Krithivas, Krishna, Brown, Myles, Brufsky, Adam, Talcott, James, Hennekens, Charles H., Kantoff, Philip W.
Baskı/Yayın Bilgisi 1997

Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy

Yazar: Sun, Tong, Lee, Gwo-Shu Mary, Werner, Lillian, Pomerantz, Mark, Oh, William K., Kantoff, Philip W., Freedman, Matthew L.
Baskı/Yayın Bilgisi 2010

Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

Yazar: Giacalone, Nicholas J., Wu, Jing, Chen, Ming-Hui, Renshaw, Andrew, Loffredo, Marian, Kantoff, Philip W., D’Amico, Anthony V.
Yayımlandı J Clin Oncol (2016)

Prostate Cancer Incidence and Mortality among Men using Statins and Non-statin Lipid-lowering Medications

Yazar: Van Rompay, Maria I., Solomon, Keith R., Nickel, J. Curtis, Ranganathan, Gayatri, Kantoff, Philip W., McKinlay, John B.
Yayımlandı Eur J Cancer (2019)

Aneuploidy drives lethal progression in prostate cancer

Yazar: Stopsack, Konrad H., Whittaker, Charles A., Gerke, Travis A., Loda, Massimo, Kantoff, Philip W., Mucci, Lorelei A., Amon, Angelika
Yayımlandı Proc Natl Acad Sci U S A (2019)